Sartorius Stedim Biotech GMBH
Budget
€25 — €0
EP Access
0
accredited persons
Staff
1
0.1 FTE
EU Grants
None
Mission & Goals
Sartorius Stedim Biotech GmBH is a leading international partner of the biopharmaceutical industry. As a provider of innovative biomanufacturing equipment solutions, the company helps its customers to manufacture biotech medications, such as monoclonal antbodies, vaccines, cell and gene therapies, safely, rapidly, and sustainably. The company has a strong global reach with manufacturing and R&D sites as well as sales entities in Europe, North America, and Asia. Sartorius Stedim Biotech regularly expands its portfolio through acquisitions of complementary technologies. In 2024, the company generated sales revenue of around 2.8 billion euros. Currently, more than 9,900 employees are working for customers around the globe.
EU Legislative Interests
European biotech Act Critical medicines Act Life Sciences strategy
Communication Activities
We are forming a new Life sciences manufactuiring association to hold discussions with the European commission starting with the topics outlined above
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Biophorum Association ISPE ( INternational Society of Pharmaceutical engineers) BPSA ( Bioprocess Systems Alliance) EuropaBio
Commissioner Meetings
No recorded meetings with EU commissioners.